Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ZOLMITRIPTAN USP, with a corresponding US DMF Number 22237.
Remarkably, this DMF maintains an Active status since its submission on December 02, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 14, 2014, and payment made on December 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II